Globeflex Capital L P Lannett CO Inc Transaction History

Globeflex Capital L P

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$5.28 - $9.64 $147,866 - $269,968	-28,005 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$5.75 - $7.13 $272,504 - $337,904	-47,392 Reduced 62.86%	28,005 $183,000
Q3 2020 Nov 13, 2020	SELL	$4.9 - $7.12 $5,796 - $8,422	-1,183 Reduced 1.54%	75,397 $461,000
Q2 2020 Aug 12, 2020	BUY	$6.43 - $9.86 $23,958 - $36,738	3,726 Added 5.11%	76,580 $556,000
Q1 2020 May 13, 2020	BUY	$6.36 - $10.05 $198,069 - $312,987	31,143 Added 74.66%	72,854 $506,000
Q4 2019 Feb 07, 2020	SELL	$8.49 - $12.81 $273,819 - $413,148	-32,252 Reduced 43.61%	41,711 $368,000
Q1 2019 May 10, 2019	BUY	$5.35 - $9.82 $301,927 - $554,191	56,435 Added 321.97%	73,963 $582,000
Q2 2018 Aug 10, 2018	SELL	$13.3 - $17.45 $191,679 - $251,489	-14,412 Reduced 45.12%	17,528 $238,000
Q1 2018 May 14, 2018	BUY	$14.7 - $24.95 $143,736 - $243,961	9,778 Added 44.12%	31,940 $513,000
Q4 2017 Feb 13, 2018	BUY	$19.9 - $29.25 $204,353 - $300,368	10,269 Added 86.34%	22,162 $514,000
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $179,584 - $228,940	11,893	11,893 $219,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.